Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA cross-linking via alkylation is a critical molecular event where bifunctional electrophilic chemicals form covalent bridges between nucleotides within or across DNA strands. This disrupts essential genetic processes leading primarily to cytotoxicity—a feature harnessed by several anticancer therapies. The specificity depends on agent structure and reactivity toward different nucleotide positions—with guanine being most susceptible—and cellular response involves complex multi-protein repair systems whose failure increases sensitivity to these damaging events.
Covalent cross-linking of DNA strands, preventing replication and transcription
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Cross-Linking via Alkylation.